- Home
- HTFL
as 10-24-2025 3:52pm EST
Stocks
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | MOUNTAIN VIEW |
| Market Cap: | 2.8B | IPO Year: | 2025 |
| Target Price: | $37.00 | AVG Volume (30 days): | 358.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -15.63 | EPS Growth: | N/A |
| 52 Week Low/High: | $26.56 - $41.22 | Next Earning Date: | 11-12-2025 |
| Revenue: | $148,540,000 | Revenue Growth: | 44.32% |
| Revenue Growth (this year): | 34.51% | Revenue Growth (next year): | 24.58% |
Latest Heartflow Inc. Common Stock News
HTFL Breaking Stock News: Dive into HTFL Ticker-Specific Updates for Smart Investing
Compare HTFL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HTFL Heartflow Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.